HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 11.70
-0.56 (-4.57%)
Jul 30, 2026, 2:14 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 10.64 billion as of July 29, 2026. Its market cap has increased by 39.68% in one year.
Market Cap
10.64B
Enterprise Value
8.14B
Revenue
1.23B
Ranking
n/a
PE Ratio
14.32
Stock Price
11.70
ChartMarket Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 10.64B, an increase of 25.70%. That is a compound annual growth rate of 4.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 10.64B | 4.63% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 13.10B |
| Metis TechBio | 12.06B |
| GenFleet Therapeutics (Shanghai) | 10.27B |
| Nanjing Leads Biolabs | 10.26B |
| Ascletis Pharma | 9.49B |
| Shaanxi Micot Pharmaceutical Technology | 9.34B |
| Everest Medicines | 8.79B |
| TenNor Therapeutics (Suzhou) | 8.78B |